Name: UMIN ID:
Unique ID issued by UMIN | UMIN000036295 |
---|---|
Receipt number | R000041294 |
Scientific Title | Phase 1 Dose Escalation Study of Bosutinib in Patients with Amyotrophic Lateral Sclerosis (ALS) |
Date of disclosure of the study information | 2019/03/26 |
Last modified on | 2021/09/22 22:33:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/03/26 13:59:53 | ||
2 | Update | 2019/04/23 11:55:26 | Institutions |
|
3 | Update | 2019/04/23 12:50:37 | Institutions |
|
4 | Update | 2019/06/11 16:42:17 | Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2020/03/24 15:07:24 | Key exclusion criteria |
|
6 | Update | 2020/03/24 15:09:03 | Address Address |
|
7 | Update | 2020/03/24 15:15:47 | Key exclusion criteria |
|
8 | Update | 2020/09/24 09:19:26 | Last follow-up date |
|
9 | Update | 2021/01/26 14:02:04 | Division name |
|
10 | Update | 2021/01/26 14:03:41 | Last follow-up date |
|
11 | Update | 2021/03/26 09:16:19 | Recruitment status |
|
12 | Update | 2021/04/20 09:46:58 | Recruitment status Last follow-up date |
|
13 | Update | 2021/07/05 08:57:43 | Email |
|
14 | Update | 2021/09/22 22:29:10 | Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Adverse events Adverse events Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |
|
15 | Update | 2021/09/22 22:32:12 | Date of closure to data entry |
|
16 | Update | 2021/09/22 22:33:22 | Recruitment status |